Skip to main content

Table 3 Biochemical patient characteristics

From: Late effects of pediatric hematopoietic stem cell transplantation on left ventricular function, aortic stiffness and myocardial tissue characteristics

  Pediatric HSCT recipients (n = 16) Normal values
Fasting glucose, mmol/L 5.1 ± 0.8 3.1–6.4
Total cholesterol, mmol/L 4.90 ± 1.20 3.90–7.30
HDL-cholesterol, mmol/L 1.30 ± 0.32 0.80–2.30
LDL-cholesterol, mmol/L 2.69 ± 0.87 0.00–3.37
Triglycerides, mmol/L 1.87 ± 1.29 0.80–2.30
Alanine aminotransferase (ALT), U/L Men: 32 ± 17 0–45
Women: 15 ± 4 0–34
Aspartate aminotransferase (AST), U/L Men: 31 ± 16 0–35
Women: 21 ± 2 0–31
Gamma-glutamyl transpeptidase (GGT), U/L Men: 40 ± 24 0–55
Women: 19 ± 10 0–38
Free thyroxin (FT4), pmol/L 15.9 ± 2.6 12.0–22.0
Thyroid-stimulating hormone (TSH), mU/L 2.695 ± 1.472 0.300–4.800
eGFR (CKD-EPI) > 60 mL/min/1.73m2, n (%) 16 (100%) NA
Ferritin, μmol/L Men: 187, 183 (61, 910) 35–260
Women: 31, 437 (8, 792) 10–150
Ferritin > 250 μmol/L, n (%) 5 (31.3%) NA
Hemoglobin, mmol/L Men: 9.0 ± 0.7 8.5–11.0
Women: 8.4 ± 0.9 7.5–10.0
  1. Values are presented as numbers (percentages), mean ± standard deviation or median, interquartile range (minimum, maximum), if the distribution was skewed. Separate values are reported for men (n = 11) and women (n = 5), if applicable. HSCT hematopoietic stem cell transplantation